View Exam | PowerPak

1. Which rheumatic disease affects men more than women?

A. Ankylosing spondylitis (AS) B. Psoriatic arthritis (PsA) C. Rheumatoid arthritis (RA) D. None of the above

2. Which drug approved for the treatment of RA is considered a targeted synthetic DMARD?

A. Apremilast B. Etanercept C. Secukinumab D. Tofacitinib

3. All patients being considered for treatment with biologic or targeted synthetic DMARDs should be screened for which infection prior to initiation of therapy?

A. Histoplasmosis B. Staphylococcus C. Streptococcus D. Tuberculosis

4. In which rheumatic disease are the symptoms of enthesitis and dactylitis relatively common?

A. AS B. PsA C. RA D. None of the above

5. Recent evidence has suggested that the interleukin-17 (IL-17)/IL-23 axis may play a role in the pathogenesis of which rheumatic disease?

A. AS B. PsA C. RA D. All of the above

6. Which class of biologic DMARDs are approved for use in patients with ankylosing spondylitis?

A. Anti-CD20 antibodies B. IL-6 inhibitors C. IL-12/IL-23 inhibitors D. TNF-α inhibitors

7. Which of the following drugs is considered a biosimilar DMARD?

A. Adalimumab B. Infliximab-dyyb C. Tocilizumab D. Ustekinumab

8. The Disease Activity Score – 28 joints (DAS28) instrument does not include which of the following criteria?

A. C-reactive protein and erythrocyte sedimentation rate B. Number of swollen and tender joints C. Patient's global health assessment D. Physician's global health assessment

9. According to American College of Rheumatology recommendations, which drug should be used in the first-line setting for patients with early or established RA?

A. Abatacept B. Glucocorticoid C. Methotrexate D. Ustekinumab

10. Herpes zoster vaccinations should not be administered to patients:

A. Prior to starting conventional synthetic DMARDs B. Who are currently taking conventional synthetic DMARDs C. Prior to starting biologic or targeted synthetic DMARDs D. Who are currently taking biologic or targeted synthetic DMARDs

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which rheumatic disease affects men more than women?

2. Which drug approved for the treatment of RA is considered a targeted synthetic DMARD?

3. All patients being considered for treatment with biologic or targeted synthetic DMARDs should be screened for which infection prior to initiation of therapy?

4. In which rheumatic disease are the symptoms of enthesitis and dactylitis relatively common?

5. Recent evidence has suggested that the interleukin-17 (IL-17)/IL-23 axis may play a role in the pathogenesis of which rheumatic disease?

6. Which class of biologic DMARDs are approved for use in patients with ankylosing spondylitis?

7. Which of the following drugs is considered a biosimilar DMARD?

8. The Disease Activity Score – 28 joints (DAS28) instrument does not include which of the following criteria?

9. According to American College of Rheumatology recommendations, which drug should be used in the first-line setting for patients with early or established RA?

10. Herpes zoster vaccinations should not be administered to patients:

« Return to Activity

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which rheumatic disease affects men more than women?

2. Which drug approved for the treatment of RA is considered a targeted synthetic DMARD?

3. All patients being considered for treatment with biologic or targeted synthetic DMARDs should be screened for which infection prior to initiation of therapy?

4. In which rheumatic disease are the symptoms of enthesitis and dactylitis relatively common?

5. Recent evidence has suggested that the interleukin-17 (IL-17)/IL-23 axis may play a role in the pathogenesis of which rheumatic disease?

6. Which class of biologic DMARDs are approved for use in patients with ankylosing spondylitis?

7. Which of the following drugs is considered a biosimilar DMARD?

8. The Disease Activity Score – 28 joints (DAS28) instrument does not include which of the following criteria?

9. According to American College of Rheumatology recommendations, which drug should be used in the first-line setting for patients with early or established RA?

10. Herpes zoster vaccinations should not be administered to patients:

« Return to Activity

Customers who Purchased
this Activity also Purchased